mdlinx mdlinx
Latest (82) Full Text Articles (1263) Focus on Anxiety Disorders Article Summary

Efficacy of olanzapine long-acting injection in patients with acutely exacerbated schizophrenia: an insight from effect size comparison with historical oral data Full Text
BMC Psychiatry,  Clinical Article

Detke HC et al. – Patients treated acutely with olanzapine long–acting injection (LAI) showed a similar pattern of improvement to that seen historically with oral olanzapine. With the exception of injection–related adverse events, the efficacy and tolerability profile of olanzapine LAI is similar to oral olanzapine.

Methods
  • Six-week results from the olanzapine LAI study (N=404) were compared with those of 3 oral studies (study 1: olanzapine vs. haloperidol vs. placebo [N=335]; study 2: olanzapine vs. haloperidol vs. low-dose olanzapine [N=431]; study 3: olanzapine vs. placebo vs. low-dose olanzapine [N=152]).
  • All patients had baseline Brief Psychiatric Rating Scale (BPRS) scores >=24 (0-6 scale).
  • Six-week effect sizes were calculated.
  • Efficacy onset, pharmacokinetics, discontinuations, weight gain, and extrapyramidal symptoms were also assessed.

Results
  • At 6 weeks, mean BPRS scores decreased by 14 to 15 points for olanzapine LAI (405 mg/4 weeks, 210 or 300 mg/2 weeks), by 8 to 16 for oral olanzapine (10+/-2.5 or 15+/-2.5 mg/day), and by 12 to 13 for haloperidol (15+/-5 mg/day).
  • For those same dose groups, effect sizes vs. placebo for the BPRS were 0.7 to 0.8 for olanzapine LAI, 0.5 to 0.7 for oral olanzapine, and 0.6 for haloperidol.
  • The first statistically significant separation from placebo on the BPRS occurred at 3 days for the olanzapine LAI groups and at 1 week for oral olanzapine and haloperidol (15+/-5 mg/day) in oral study 1 although as late as week 6 for the 10-mg/day olanzapine dose in oral study 3.
  • Olanzapine concentrations were similar across studies.
  • Weight gain >=7% of baseline occurred in up to 35% of olanzapine LAI and oral patients versus up to 12% of haloperidol and placebo patients.
  • Extrapyramidal symptoms were lowest in the olanzapine LAI groups and significantly greater in the haloperidol groups.
  • No post-injection delirium/sedation syndrome events occurred in the olanzapine LAI study.

Please login or register to follow this author.
Are you sure you want to Unfollow this Author?
► Click here to access Full Text, PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Psychiatry

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Psychiatry Articles

Last month's top read Top Articles of 2013

1 Vitamin D supplementation for depressive symptoms: a systematic review and meta-analysis of randomized controlled trials Psychosomatic Medicine, March 20, 2014    Evidence Based Medicine    Review Article    Clinical Article

2 Melatonin for prevention of metabolic side-effects of olanzapine in patients with first-episode schizophrenia: Randomized double-blind placebo-controlled study Journal of Psychiatric Research, March 14, 2014    Clinical Article
Exclusive Author Commentary

3 Selective serotonin reuptake inhibitor drug interactions in patients receiving statins The Journal of Clinical Psychiatry, March 5, 2014    Clinical Article

4 Salivary exoglycosidases as a markers of alcohol dependence Alcohol and Alcoholism , March 17, 2014    Clinical Article

5 Effect of reiki therapy on pain and anxiety in adults: an in-depth literature review of randomized trials with effect size calculations Pain Management Nursing, March 19, 2014    Review Article    Clinical Article

6 Cognitive effects of statin medications CNS Drugs, February 18, 2014    Clinical Article

7 A comparative review of escitalopram, paroxetine, and sertraline: Are they all alike? International Clinical Psychopharmacology, January 15, 2014    Review Article    Clinical Article

8 Pharmacological strategies to counteract antipsychotic-induced weight gain and metabolic adverse effects in schizophrenia: a systematic review and meta-analysis Schizophrenia Bulletin, March 25, 2014    Evidence Based Medicine

9 Agomelatine: A new option for treatment of depression? Expert Opinion on Pharmacotherapy, February 14, 2014    Clinical Article

10 Mindfulness-based cognitive therapy (MBCT) versus the health-enhancement program (HEP) for adults with treatment-resistant depression: a randomized control trial study protocol Full Text BMC Complementary and Alternative Medicine, March 12, 2014    Free full text    Clinical Article

11 Bipolar or borderline: A clinical overview Acta Psychiatrica Scandinavica, February 27, 2014    Review Article

12 Hypnotherapy is more effective than nicotine replacement therapy for smoking cessation: Results of a randomized controlled trial Complementary Therapies in Medicine, March 3, 2014    Clinical Article

13 Pregabalin in acute treatment of anxious depression: A case series Psychiatry Research, February 13, 2014    Clinical Article

14 Revisiting the therapeutic effect of rTMS on negative symptoms in schizophrenia: A meta-analysis Psychiatry Research, March 10, 2014    Evidence Based Medicine

15 A six month randomized controlled trial of long acting injectable risperidone 50 and 100mg in treatment resistant schizophrenia Schizophrenia Research, March 26, 2014    Clinical Article

16 Psychodynamic psychotherapy versus cognitive behavior therapy for social anxiety disorder: An efficacy and partial effectiveness trial Depression and Anxiety, February 28, 2014    Clinical Article

17 Lurasidone monotherapy in the treatment of bipolar I depression: A randomized, double-blind, placebo-controlled study American Journal of Psychiatry, February 7, 2014    Clinical Article

18 Electronic cigarette use outcome expectancies among college students Addictive Behaviours, March 11, 2014    Clinical Article

19 Gabapentin treatment for alcohol dependence: A randomized clinical trial JAMA Internal Medicine, January 10, 2014    Evidence Based Medicine    Clinical Article

20 Cannabis and psychosis: Neurobiology Full Text Indian Journal of Psychiatry, January 17, 2014    Free full text    Review Article

Indexed Journals in Psychiatry : Current Psychiatry, Bipolar Disorders, American Journal of Psychiatry, Addictionmore

Other Topics in Psychiatry

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Stay current - Media Tool

Newsletter
RSS
Follow
Like

Receive the latest mecial news
updates for free via email

Sign up!

Subscribe to our free RSS feeds:

Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Close